A Novel Step-Up Dosage Regimen for Enhancing the Benefit-to-Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma
一种提高莫苏妥珠单抗治疗复发或难治性滤泡性淋巴瘤获益风险比的新型递增剂量方案
期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.3445
Li, Chi-Chung; Bender, Brendan; Wilkins, Justin; Li, Feifei; Turner, David C; Wang, Bei; Deng, Rong; Vadhavkar, Shweta; Li, Zao; Kwan, Antonia; Huang, Huang; Peng, Kun; Penuel, Elicia; Huw, Ling-Yuh; Chanu, Pascal; Li, Chunze; Yin, Shen; Wei, Michael C